Laurion Capital Management »

Unity Biotechnology shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Unity Biotechnology (UBX) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Unity Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Unity Biotechnology held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unity Biotechnology by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $42k 22k 1.93
2023-09-30 $168k 70k 2.40
2023-06-30 $179k 70k 2.55
2023-03-31 $114k 70k 1.63
2022-12-31 $192k 70k 2.74

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A Call Option (META)
Apple (AAPL)
Tesla Motors Call Option (TSLA)
Kenvue (KVUE)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Adobe Systems Incorporated Call Option (ADBE)
Alphabet Cap Stk Cl C Call Option (GOOG)
Bridgebio Pharma (BBIO)
NVIDIA Corporation Call Option (NVDA)
Bank of America Corporation (BAC)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Intel Corporation Call Option (INTC)

View all positions for Laurion Capital Management

Top funds holding Unity Biotechnology

Alyeska Investment Group
Arch Venture Corp
Vanguard Group
Citadel Advisors
Founders Fund V Management
Wells Fargo & Company
Cercano Management
Jane Street
Dimensional Fund Advisors
Commonwealth Equity Services
Laurion Capital Management
Millennium Management
Advisor Group Holdings
Wolverine Trading
UBS Group

View all funds holding Unity Biotechnology